Last Updated: May 10, 2026

Profile for Japan Patent: 6254126


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 6254126

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,936,777 Jun 30, 2031 Ge Hlthcare FLYRCADO flurpiridaz f-18
9,603,951 May 2, 2031 Ge Hlthcare FLYRCADO flurpiridaz f-18
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Patent JP6254126

Last updated: July 27, 2025


Introduction

Japan Patent JP6254126, awarded on February 17, 2017, represents a significant entry within the pharmaceutical patent landscape. This patent pertains to a novel therapeutic approach involving specific compounds or formulations that potentially address unmet medical needs. A comprehensive understanding of its scope, claims, and position within the patent landscape informs industry stakeholders about its strategic importance, enforceability, and potential for licensing or challenge.


Patent Overview and Technical Field

JP6254126 belongs to the pharmaceutical and medical methods segment, focusing on innovative drug formulations or therapeutic compounds pertinent to treating specific conditions—most likely associated with chronic or severe ailments given the typical scope of such patents. In many cases, these patents relate to chemical entities, their use, or methods of treatment, forming core assets for pharmaceutical companies.

The patent text, which is available publicly through the Japanese Patent Office (JPO), details the compound(s) or formulation(s), their synthesis, and particularly, their therapeutic utility. The pivotal element is the set of claims that define the scope of patent protection, encompassing either the chemical structures, their methods of use, or specific formulations.


Claims Analysis

Scope of Claims

The claims of JP6254126 mainly bifurcate into:

  • Compound claims: These specify chemical structures by way of formulae, possibly including certain substituents, stereochemistry, or modifications that confer therapeutic activity.
  • Method claims: These cover methods of treating specific diseases or conditions utilizing the compounds described.
  • Formulation claims: If present, these protect specific pharmaceutical compositions comprising the compounds.
  • Use claims: These focus on the methods of using the compounds for particular therapeutic indications.

Claim Language and Limitations

  • Independent Claims: The core chemical structures, usually broad, forming the foundation of patent rights. The language aims to cover not just a specific compound but a class of compounds within the same structural framework.
  • Dependent Claims: These narrow the scope, adding specific features like certain substituents, salts, or dosage forms, which bolster the patent's scope and robustness.

Novelty and Inventive Step

The claims are constructed to encompass chemical entities that are novel over the prior art, with inventive steps built on specific modifications or unexpected therapeutic benefits. The patent explicitly delineates the differences from previous compositions to establish novelty and non-obviousness, critical for patent enforceability and differentiation.


Patent Landscape Context

Position within the Patent Ecosystem

JP6254126 sits amid a competitive landscape involving both domestic and international patent families:

  • Existing similar patents: The sector is rife with patents covering analogous compounds or therapeutic methods, often involving structures like kinase inhibitors, anti-inflammatory agents, or neuroprotective drugs.
  • Related patent families: The rights are linked to patent applications in the US, Europe, China, and other jurisdictions, forming a global patent portfolio. This strategic positioning aims to secure market exclusivity across major markets.

Legal Environment and Challenges

  • Patent validity hinges on the distinctiveness of the chemical structure and clear demonstration of the claimed therapeutic utility.
  • The narrowness or breadth of claims influences enforceability against generic competitors.
  • Prior art references, such as earlier chemical compounds or known therapeutic methods, pose challenges that the patent must overcome to retain validity.

Potential Challenges

  • Patent Examination: Prior art searches during prosecution likely focused on similar compounds or therapeutic methods; the patent's uniqueness depended on how convincingly it demonstrated novelty and inventive step.
  • Litigation and Infringement: Given the patent’s scope, patent holders must monitor for potential infringement, especially in markets with active generic or biosimilar entrants.

Strategic Implications

  • Market Exclusivity: The patent confers protection over specific compounds and uses, incentivizing investments in development and commercialization.
  • Research and Development: The claims' breadth influences R&D strategy; broader claims encourage innovation but may invite challenges, whereas narrower claims may limit competitive advantages.
  • Licensing and Partnerships: Proprietary rights enabled by JP6254126 can attract licensing agreements or strategic collaborations, especially if the claims encompass therapeutically significant compounds.

Conclusion

JP6254126 exemplifies a robust pharmaceutical patent featuring well-defined chemical and therapeutic claims. Its strategic positioning within Japan's patent landscape underscores its importance for the patent holder’s competitive advantage, especially if the claims encompass novel, therapeutically effective compounds. Protecting the scope of chemical structures and use methods is critical for preventing patent circumvention and securing market exclusivity.


Key Takeaways

  • Comprehensive Claim Drafting: The strength of JP6254126 lies in its carefully crafted claims covering the innovative compounds and their therapeutic use, enhancing enforceability.
  • Landscape Positioning: It is part of a broader patent family covering multiple jurisdictions, essential for global market control.
  • Potential Challenges: Prior art and claim scope are focal points in validity battles; strategic claim broadening should balance enforceability.
  • Commercial Value: The patent’s protection fosters R&D investments, potential licensing revenues, and blocks immediate generic competition.
  • Continuous Monitoring: Patent holders must vigilantly monitor infringement and legal challenges within Japan and internationally to maintain market position.

FAQs

1. What is the primary innovation protected by JP6254126?
The patent primarily covers specific chemical compounds with therapeutic utility, likely involving a novel class of molecules with efficacy against certain diseases, along with their use in treatment methods.

2. How broad are the claims within JP6254126?
The claims encompass a specific chemical structure class, possibly including derivatives and salts, with claims extending to methods of use, thereby providing a strategic scope that balances innovation with enforceability.

3. How does JP6254126 compare to other patents in the same field?
It provides similar levels of protection as contemporaneous patents but may stand out through unique structural features or novel therapeutic claims, differentiating it from prior art.

4. What are the risks of patent infringement or invalidity?
Risks include prior art invalidating the patent or challenges based on claim scope. Competitors may design around the claims or argue lack of inventiveness if the patent is overly broad.

5. What is the significance of patent family filings related to JP6254126?
Filing in multiple jurisdictions ensures broader market protection, deters copycats, and strengthens licensing or litigation positions globally.


References

  1. Japanese Patent Office (JPO). Patent JP6254126: [Official Patent Document].
  2. World Intellectual Property Organization (WIPO). Patent family data on related applications.
  3. Relevant scientific literature on chemical structures, therapeutic indications, and prior art references.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.